Edwards Lifesciences (EW) Gross Profit Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.85% |
| Dec 31, 2025 | 6.50% |
| Sep 30, 2025 | 7.03% |
| Jun 30, 2025 | 11.58% |
| Mar 31, 2025 | 5.17% |
| Dec 31, 2024 | 4.26% |
| Sep 30, 2024 | 6.37% |
| Jun 30, 2024 | 6.92% |
| Mar 31, 2024 | 6.50% |
| Dec 31, 2023 | 6.45% |
| Sep 30, 2023 | 7.81% |
| Jun 30, 2023 | 8.13% |
| Mar 31, 2023 | 8.46% |
| Dec 31, 2022 | -4.14% |
| Sep 30, 2022 | 11.86% |
| Jun 30, 2022 | 11.86% |
| Mar 31, 2022 | 9.30% |
| Dec 31, 2021 | 12.97% |
| Sep 30, 2021 | 13.17% |
| Jun 30, 2021 | 13.35% |
| Mar 31, 2021 | 12.30% |
| Dec 31, 2020 | 12.58% |
| Sep 30, 2020 | 12.90% |
| Jun 30, 2020 | 8.43% |
| Mar 31, 2020 | 13.71% |
| Dec 31, 2019 | 14.18% |
| Sep 30, 2019 | 12.78% |
| Jun 30, 2019 | 13.05% |
| Mar 31, 2019 | 15.12% |
| Dec 31, 2018 | 13.63% |
| Sep 30, 2018 | 13.16% |
| Jun 30, 2018 | 12.12% |
| Mar 31, 2018 | 11.97% |
| Dec 31, 2017 | 11.17% |
| Sep 30, 2017 | 12.59% |
| Jun 30, 2017 | 12.36% |
| Mar 31, 2017 | 15.01% |
| Dec 31, 2016 | 12.29% |
| Sep 30, 2016 | 13.38% |
| Jun 30, 2016 | 12.91% |
| Mar 31, 2016 | 12.44% |
| Dec 31, 2015 | 12.17% |
| Sep 30, 2015 | 13.12% |
| Jun 30, 2015 | 11.59% |
| Mar 31, 2015 | 13.43% |
| Dec 31, 2014 | 13.31% |
| Sep 30, 2014 | 14.10% |
| Jun 30, 2014 | 12.66% |